Fenoldopam

Generic Name
Fenoldopam
Brand Names
Corlopam
Drug Type
Small Molecule
Chemical Formula
C16H16ClNO3
CAS Number
67227-56-9
Unique Ingredient Identifier
INU8H2KAWG
Background

A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.

Indication

用于极严重高血压或住院不能口服药物的高血压患者初1~2天的对症处理。

Associated Conditions
Malignant Hypertension, Severe Hypertension
Associated Therapies
-

Fenoldopam to Prevent Renal Dysfunction in Indomethacin Treated Preterm Infants

First Posted Date
2015-12-03
Last Posted Date
2022-09-16
Lead Sponsor
Medical College of Wisconsin
Target Recruit Count
1
Registration Number
NCT02620761
Locations
🇺🇸

University of Iowa, Iowa City, Iowa, United States

Intervention Study to Compare the Natriuretic Effects of Enalapril on Low and High Salt Diet

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2011-03-28
Last Posted Date
2011-03-28
Lead Sponsor
Georgetown University
Target Recruit Count
45
Registration Number
NCT01324245
Locations
🇺🇸

Georgetown University Medical Center, Washington, District of Columbia, United States

Fenoldopam in Pediatric Cardiac Surgery

Phase 3
Completed
Conditions
Interventions
First Posted Date
2009-09-23
Last Posted Date
2012-06-28
Lead Sponsor
Bambino Gesù Hospital and Research Institute
Target Recruit Count
80
Registration Number
NCT00982527
Locations
🇮🇹

Bambino Gesù Hospital, Rome, Lazio, Italy

The Effect of Fenoldopam in Solitary Partial Nephrectomy Surgery

Not Applicable
Terminated
Conditions
Interventions
First Posted Date
2008-08-28
Last Posted Date
2018-09-19
Lead Sponsor
The Cleveland Clinic
Target Recruit Count
90
Registration Number
NCT00743106
Locations
🇺🇸

Cleveland Clnic, Cleveland, Ohio, United States

Fenoldopam and Acute Renal Failure

Phase 3
Completed
Conditions
Interventions
First Posted Date
2008-02-22
Last Posted Date
2015-10-14
Lead Sponsor
Università Vita-Salute San Raffaele
Target Recruit Count
667
Registration Number
NCT00621790
Locations
🇮🇹

Università Vita-Salute San Raffaele, Milano, Italia e Istituto Scientifico San Raffaele, Milano, Italia, Milano, Italy

🇮🇹

Pres.Ospedal. Spedali Civili Brescia - Brescia, Brescia, Italy

🇮🇹

Azienda Ospedaliera Universitaria "Mater Domini" Catanzaro, Catanzaro, Italy

and more 16 locations

Effect of Gene Variants on Dopamine Receptor Natriuretic Responses

Phase 1
Conditions
Interventions
First Posted Date
2008-01-11
Last Posted Date
2013-01-23
Lead Sponsor
University of Virginia
Target Recruit Count
44
Registration Number
NCT00592150
Locations
🇺🇸

University of Virginia, Charlottesville, Virginia, United States

A Pilot Study to Investigate Fenoldopam Usage in the Prevention of Postoperative Renal Dysfunction in Patients at a High Risk for Renal Impairment During Cariopulmonary Bypass for Cardiac Surgery

First Posted Date
2007-04-27
Last Posted Date
2008-01-30
Lead Sponsor
Summa Health System
Target Recruit Count
30
Registration Number
NCT00467181
Locations
🇺🇸

Summa Health System, Akron, Ohio, United States

An Investigation of N-acetylcysteine and Fenoldopam as Renal Protection Agents for Cardiac Surgery

First Posted Date
2005-07-21
Last Posted Date
2014-11-07
Lead Sponsor
Linda F. Barr, M.D.
Target Recruit Count
80
Registration Number
NCT00122018
© Copyright 2024. All Rights Reserved by MedPath